Guangdong Taiantang Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 255.29 million compared to CNY 504.95 million a year ago. Revenue was CNY 261.14 million compared to CNY 509.74 million a year ago.

Net loss was CNY 106.1 million compared to CNY 113.34 million a year ago. Basic loss per share from continuing operations was CNY 0.14 compared to CNY 0.15 a year ago. Diluted loss per share from continuing operations was CNY 0.14 compared to CNY 0.15 a year ago.